Metabolite profiling of RCS-4, a novel synthetic cannabinoid designer drug, using human hepatocyte metabolism and TOF-MS.
about
Pentylindole/Pentylindazole Synthetic Cannabinoids and Their 5-Fluoro Analogs Produce Different Primary Metabolites: Metabolite Profiling for AB-PINACA and 5F-AB-PINACAIdentification of AB-FUBINACA metabolites in authentic urine samples suitable as urinary markers of drug intake using liquid chromatography quadrupole tandem time of flight mass spectrometry.Nontargeted SWATH acquisition for identifying 47 synthetic cannabinoid metabolites in human urine by liquid chromatography-high-resolution tandem mass spectrometry.Synthetic cannabinoids pharmacokinetics and detection methods in biological matrices.High-resolution mass spectrometry in toxicology: current status and future perspectives.Distribution of Synthetic Cannabinoids JWH-210, RCS-4 and Δ 9-Tetrahydrocannabinol After Intravenous Administration to Pigs.Metabolic patterns of JWH-210, RCS-4, and THC in pig urine elucidated using LC-HR-MS/MS: Do they reflect patterns in humans?Metabolism and bioactivation of the tricyclic antidepressant amitriptyline in human liver microsomes and human urine.In Vitro Metabolite Profiling of ADB-FUBINACA, A New Synthetic Cannabinoid.Identification of AKB-48 and 5F-AKB-48 Metabolites in Authentic Human Urine Samples Using Human Liver Microsomes and Time of Flight Mass Spectrometry.Toxicokinetics of new psychoactive substances: plasma protein binding, metabolic stability, and human phase I metabolism of the synthetic cannabinoid WIN 55,212-2 studied using in vitro tools and LC-HR-MS/MS.Structure–activity relationships of synthetic cannabinoid designer drug RCS-4 and its regioisomers and C4 homologues
P2860
Q34464722-C2F6D195-3144-489F-860C-4EA4D419199BQ34501432-D42BF117-C863-4E1E-92AD-5024C270ED35Q35254099-487EAB11-7E1C-49FB-8D37-C89947C87C14Q38411456-7933324A-647D-4CE9-80A3-BB295FBE0E04Q38846184-F3E08301-AF84-40D7-84DF-CA525EFAAB1BQ39196884-6C641958-621A-49C2-9176-5F2BD8097E01Q39666362-2E86D0CE-3BAD-4E80-AEE3-CEE6DE999C9FQ39699121-B224F321-7017-4620-AEF9-9A5B6259F914Q49227467-C2023A9A-FF0A-4EEB-8846-EB7E0F11BA90Q50277873-5BA19C70-1400-4BF4-AC5A-31D28BEC700BQ52887320-1EB721EC-A232-44D8-B7DB-4B5C77B55569Q58428304-07DED22C-8D03-4205-8AD5-39CA4D1FB765
P2860
Metabolite profiling of RCS-4, a novel synthetic cannabinoid designer drug, using human hepatocyte metabolism and TOF-MS.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Metabolite profiling of RCS-4, ...... atocyte metabolism and TOF-MS.
@ast
Metabolite profiling of RCS-4, ...... atocyte metabolism and TOF-MS.
@en
Metabolite profiling of RCS-4, ...... atocyte metabolism and TOF-MS.
@nl
type
label
Metabolite profiling of RCS-4, ...... atocyte metabolism and TOF-MS.
@ast
Metabolite profiling of RCS-4, ...... atocyte metabolism and TOF-MS.
@en
Metabolite profiling of RCS-4, ...... atocyte metabolism and TOF-MS.
@nl
prefLabel
Metabolite profiling of RCS-4, ...... atocyte metabolism and TOF-MS.
@ast
Metabolite profiling of RCS-4, ...... atocyte metabolism and TOF-MS.
@en
Metabolite profiling of RCS-4, ...... atocyte metabolism and TOF-MS.
@nl
P2093
P2860
P356
P1433
P1476
Metabolite profiling of RCS-4, ...... atocyte metabolism and TOF-MS.
@en
P2093
Adarsh S Gandhi
Ariane Wohlfarth
Karl B Scheidweiler
Marilyn A Huestis
Mingshe Zhu
Shaokun Pang
P2860
P304
P356
10.4155/BIO.14.13
P577
2014-06-01T00:00:00Z